concept

TAU PROTEIN

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TAU PROTEIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

318Connections

1Hypotheses

6Analyses

50Outgoing

50Incoming

0Experiments

10Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	TAU PROTEIN
Key Genes/Proteins	NFKB, VPS35
Related Diseases	Alzheimer's Disease, Tauopathies

Pathway Diagram

graph TD
    TAU_PROTEIN["TAU PROTEIN"]
    style TAU_PROTEIN fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
    TAU_PROTEIN -.->|"biomarker for"| Alzheimer_s_Disease["Alzheimer's Disease"]
    TAU_PROTEIN -.->|"biomarker for"| Tauopathies["Tauopathies"]
    TAU_PROTEIN -->|"involved_in"| Hyperphosphorylation["Hyperphosphorylation"]
    TAU_PROTEIN -->|"expressed in"| Retina["/Retina/"]
    TAU_PROTEIN -->|"causes"| Alzheimer_S_Disease["Alzheimer'S Disease"]
    TAU_PROTEIN -->|"interacts"| NFKB([NFKB])
    TAU_PROTEIN -->|"causes"| neuronal_damage["neuronal damage"]
    TAU_PROTEIN -->|"activates"| Reactive_oxygen_species["Reactive oxygen species"]
    Alzheimer_s_Disease -.->|"biomarker for"| TAU_PROTEIN
    Cerebrospinal_Fluid["Cerebrospinal Fluid"] -->|"component_of"| TAU_PROTEIN
    Post_translational_Modificatio["Post-translational Modifications"] -->|"regulates"| TAU_PROTEIN
    MAPT([MAPT]) -->|"encodes"| TAU_PROTEIN
    NBR1([NBR1]) -->|"interacts"| TAU_PROTEIN
    CBD{"CBD"} -->|"regulates"| TAU_PROTEIN
    Cannabidiol{"Cannabidiol"} -.->|"inhibits"| TAU_PROTEIN
    FBXW7([FBXW7]) -->|"regulates"| TAU_PROTEIN

Outgoing (132)

Target	Relation	Type	Str
Neurofibrillary Tangles	causes	entity	0.95
Hyperphosphorylation	involved_in	process	0.95
Alzheimer's Disease	associated_with	disease	0.95
Alzheimer's Disease	biomarker_for	disease	0.95
Alzheimer'S Disease	contributes_to	disease	0.95
Tauopathies	involved_in	disease	0.95
Tauopathies	biomarker_for	disease	0.95
Axonal Transport	regulates	process	0.92
Axonal Structure	regulates	structure	0.92
Tau Propagation	mediates	phenotype	0.90
Alzheimer'S Disease	causes	disease	0.90
neurodegeneration	causes	phenotype	0.90
cytoskeletal remodeling	associated_with	process	0.90
Retina	expressed_in	cell_type	0.90
tau protein hyperphosphorylation	involved_in	process	0.90
CSF tau assays	biomarker_for	process	0.88
Alzheimer's Disease	causes	disease	0.80
NFKB	interacts_with	protein	0.80
neurofibrillary tangles	promotes	process	0.70
Reactive oxygen species	activates	process	0.70
cognitive dysfunction	associated_with	process	0.70
phosphatidylserine	regulates	gene	0.70
Alzheimer's disease	associated_with	disease	0.70
membrane curvature	associated_with	gene	0.70
Alzheimer's disease	associated_with	disease	0.70
RNA-binding proteins	interacts_with	protein	0.70
TAU Aggregation	activates	phenotype	0.70
Neuronal dysfunction	causes	phenotype	0.70
RNA	interacts_with	process	0.70
TREM2	activates	protein	0.70
neuronal damage	causes	process	0.70
Alzheimer's disease	causes	disease	0.70
fibrillar structures	promotes	process	0.70
neurodegenerative diseases	associated_with	disease	0.70
trans-synaptic propagation	associated_with	process	0.70
Oxidative Stress	interacts_with	process	0.70
Parkinson's Disease	implicated_in	disease	0.65
Alzheimer	activates	disease	0.60
Neurodegeneration	activates	disease	0.60
Als	stabilizes	disease	0.60
Alzheimer	protects_against	disease	0.60
Als	biomarker_for	disease	0.60
Alzheimer	biomarker_for	disease	0.60
Frontotemporal Dementia	stabilizes	disease	0.60
Neuroinflammation	biomarker_for	disease	0.60
Aging	biomarker_for	disease	0.60
Neurodegeneration	causes	disease	0.60
Alzheimer	causes	disease	0.60
Neuroinflammation	therapeutic_target	disease	0.60
Dementia	stabilizes	disease	0.60

Incoming (186)

Source	Relation	Type	Str
MAPT	associated_with	gene	0.95
MAPT	associated_with	gene	0.95
37236970	is a pathological hallmark of	paper	0.90
41090735	plays pivotal roles in	paper	0.90
MAPT	regulates	gene	0.90
Hyperphosphorylation	modulates	process	0.90
VPS35	regulates	protein	0.85
MTOR	regulates	gene	0.80
Post-translational Modifications	regulates	process	0.80
MTOR	enhances	gene	0.80
MAPT	encodes	gene	0.70
Cannabidiol	inhibits	drug	0.70
HSP90AA1	regulates	protein	0.70
Alzheimer's disease	associated_with	disease	0.70
HSPA1A	regulates	protein	0.70
APOE	regulates	protein	0.70
FYN	regulates	protein	0.70
NBR1	interacts_with	protein	0.70
CBD	regulates	drug	0.70
VDAC1	regulates	protein	0.70
STUB1	modulates	protein	0.70
LRP1	regulates	gene	0.70
NBR1	regulates	protein	0.70
MAPT	encodes	gene	0.70
MTOR	activates	gene	0.70
AADvac1	targets	drug	0.70
tau-targeting antibodies	targets	drug	0.70
ALZHEIMER	protects_against	gene	0.60
AMYLOID	stabilizes	gene	0.60
TAU	therapeutic_target	gene	0.60
MICROTUBULES	stabilizes	gene	0.60
RAB7A	stabilizes	gene	0.60
NEUROGRANIN	biomarker_for	gene	0.60
TAU	biomarker_for	gene	0.60
APOE	associated_with	gene	0.60
APOPTOSIS	inhibits	gene	0.60
NFL	biomarker_for	gene	0.60
BACE1	biomarker_for	gene	0.60
ALZHEIMER	stabilizes	gene	0.60
ALZHEIMER	biomarker_for	gene	0.60
DEMENTIA	therapeutic_target	gene	0.60
ERK	inhibits	gene	0.60
TSG101	stabilizes	gene	0.60
FLAVONOIDS	inhibits	gene	0.60
NFKB	inhibits	gene	0.60
HUNTINGTON	therapeutic_target	gene	0.60
JUN	therapeutic_target	gene	0.60
PARKINSON	therapeutic_target	gene	0.60
AMYLOID	inhibits	gene	0.60
TAU	inhibits	gene	0.60

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Pericyte senescence is sufficient to weaken the BBB even wit	0.630	neurodegeneration	Does pericyte senescence drive BBB break

Mentioning Analyses (6)

Scientific analyses that reference this entity

TREM2 in Alzheimer's Disease: Mechanisms, Therapeutics, and Biomarkers

neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.861

Do tau aggregates represent protective responses or primary pathogenic drivers i

neurodegeneration | 2026-04-11 | 0 hypotheses

Can nanobodies achieve selective membrane penetration into tau-containing vesicl

molecular biology | 2026-04-09 | 7 hypotheses Top: 0.455

What are the minimal structural requirements for HSP70/HSP90 inhibitors to achie

drug discovery | 2026-04-09 | 7 hypotheses Top: 0.455

Senescent cell clearance as neurodegeneration therapy

neurodegeneration | 2026-04-02 | 7 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (10)

Multi-agent debates referencing this entity

Extended debate: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegenera

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Hypothesis debate: TREM2-Mediated Microglial Dysfunction Disrupts Perivascular T

closed · Rounds: 4 · Score: 0.50 · 2026-04-27

Hypothesis debate: TREM2-Dependent Microglial Senescence Transition

closed · Rounds: 4 · Score: 0.64 · 2026-04-26

Hypothesis debate: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegene

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

What are the key mechanistic, therapeutic, and diagnostic dimensions of TREM2 in

closed · Rounds: 4 · Score: 0.92 · 2026-04-26

The debate highlighted fundamental disagreement about tau's role - whether aggre

closed · Rounds: 4 · Score: 1.00 · 2026-04-20

What are the minimal structural requirements for HSP70/HSP90 inhibitors to achie

closed · Rounds: 4 · Score: 0.86 · 2026-04-10

Can nanobodies achieve selective membrane penetration into tau-containing vesicl

closed · Rounds: 4 · Score: 0.95 · 2026-04-10

Investigate prion-like spreading of tau pathology through connected brain region

closed · Rounds: 4 · Score: 0.88 · 2026-04-02

Senescent cell clearance as neurodegeneration therapy

closed · Rounds: 4 · Score: 0.95 · 2026-04-02

Related Research

Hypotheses and analyses mentioning TAU PROTEIN in their description or question text

No additional research found

TAU PROTEIN

Understanding Entity Pages

Pathway Diagram

Outgoing (132)

Incoming (186)

Targeting Hypotheses (1)

Mentioning Analyses (6)

TREM2 in Alzheimer's Disease: Mechanisms, Therapeutics, and Biomarkers

Do tau aggregates represent protective responses or primary pathogenic drivers i

Can nanobodies achieve selective membrane penetration into tau-containing vesicl

What are the minimal structural requirements for HSP70/HSP90 inhibitors to achie

Senescent cell clearance as neurodegeneration therapy

Tau propagation mechanisms and therapeutic interception points

Experiments (0)

Related Papers (0)

Debates (10)

Extended debate: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegenera

Hypothesis debate: TREM2-Mediated Microglial Dysfunction Disrupts Perivascular T

Hypothesis debate: TREM2-Dependent Microglial Senescence Transition

Hypothesis debate: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegene

What are the key mechanistic, therapeutic, and diagnostic dimensions of TREM2 in

The debate highlighted fundamental disagreement about tau's role - whether aggre

What are the minimal structural requirements for HSP70/HSP90 inhibitors to achie

Can nanobodies achieve selective membrane penetration into tau-containing vesicl

Investigate prion-like spreading of tau pathology through connected brain region

Senescent cell clearance as neurodegeneration therapy

Related Research